Fevertree Drinks PLC (AIM:FEVR)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 952.14M |
| Revenue (ttm) | 325.00M |
| Net Income (ttm) | 22.60M |
| Shares Out | 114.72M |
| EPS (ttm) | 0.19 |
| PE Ratio | 44.58 |
| Forward PE | 29.36 |
| Dividend | 0.17 (2.08%) |
| Ex-Dividend Date | May 21, 2026 |
| Volume | 334,774 |
| Average Volume | 305,710 |
| Open | 833.00 |
| Previous Close | 832.50 |
| Day's Range | 826.00 - 836.50 |
| 52-Week Range | 711.00 - 1,020.00 |
| Beta | 1.16 |
| RSI | 51.43 |
| Earnings Date | Sep 11, 2026 |
About Fevertree Drinks
Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company offers tonics, soft drinks, non-alcoholic, sodas, gingers, ready to drink, cocktail mixers, and cola and lemonades. It sells its products under the Fever-Tree brand name. The company was formerly known as Fevertree Topco Limited and changed its name to Fevertree Drinks PLC in October 2014. Fevertree Drinks PLC was founded in 2003 and is headquartered in Londo... [Read more]
Financial Performance
In 2025, Fevertree Drinks's revenue was 325.00 million, a decrease of -11.80% compared to the previous year's 368.50 million. Earnings were 22.60 million, a decrease of -7.38%.
Financial StatementsNews
Fevertree Drinks Earnings Call Transcript: H2 2025
Revenue grew 4% in 2025, driven by U.S. expansion and product diversification, with strong cash generation and improved margins. The Molson Coors partnership and robust supply chain position support confidence in 2026 EBITDA growth despite ongoing geopolitical risks.
Fevertree Drinks Earnings Call Transcript: H1 2025
H1 FY25 saw robust financials, with 2% constant currency growth and strong U.S. momentum from the Molson Coors partnership. Product diversification, especially ginger beer, is driving growth, while the expanded share buyback reflects confidence in future cash flows.
Fevertree and Molson Coors to split cost of US tariffs
Tonic maker Fevertree Drinks said on Thursday it would equally split costs of the 10% tariff to be imposed on the UK imports to the U.S. with brewer Molson Coors , as part of their recent tie-up to mi...
Fevertree Drinks Earnings Call Transcript: H2 2024
Fever-Tree achieved 4% constant currency growth in 2024, with strong U.S. and Rest of World performance, margin recovery, and robust cash generation. The Molson Coors partnership is set to drive future growth, profitability, and shareholder returns.
Fevertree Drinks Transcript: Partnership
A new long-term partnership with Molson Coors will see them manage U.S. sales, distribution, and production, enabling Fever-Tree to leverage Molson Coors' scale, reduce working capital, and focus on brand growth. Guaranteed royalties and a shareholding stake de-risk profits and support long-term expansion.
Molson Coors buys 8.5% stake in UK's Fevertree for $88 million
Coors Light beer maker Molson Coors will take a 8.5% stake in UK's Fevertree Drinks for 71 million pounds ($88.3 million) to expand its portfolio of non-alcoholic beverage offerings in the U.S., the c...
Fevertree Drinks Earnings Call Transcript: H1 2024
Delivered strong H1 2024 results with 79% EBITDA growth and 520 bps gross margin improvement, driven by robust U.S. and Rest of World performance, portfolio diversification, and continued investment in innovation. Outlook remains positive with further margin recovery and growth expected.
Tonic maker Fevertree cuts revenue forecast as wet weather dampens sales
Fevertree Drinks cut its annual revenue growth forecast on Thursday as unexpected wet weather at the start of its key summer season dampened sales for the British beverage maker, sending shares down 8...
Tonic maker Fevertree reiterates annual forecast ahead of key summer season
British tonic maker Fevertree Drinks , on Thursday, reiterated its forecast for the year, ahead of the key summer trading period as more customers spend on cocktails like mojitos and margaritas.
Fevertree Drinks Earnings Call Transcript: H2 2023
Fevertree's annual profit meets estimates on strong US performance
British tonic maker Fevertree Drinks posted an annual profit in line with estimates, buoyed by a robust performance of its U.S. market and increased regional production to offset inflationary pressure...
Fevertree Drinks sees annual core profit falling short of market expectations
British tonic maker Fevertree Drinks forecast annual core profit to fall short of market expectations, even as profit doubled in the second half on strong U.S. market performance, offsetting inflation...
Fevertree Drinks Earnings Call Transcript: H1 2023
Fevertree Drinks Earnings Call Transcript: H2 2022
Fevertree Drinks Earnings Call Transcript: H1 2022
Fevertree Drinks Earnings Call Transcript: H1 2022
Tonic maker Fevertree cuts profit forecast as cost pressures increase
Tonic maker Fevertree lowered its annual profit forecast on Friday, signalling a hit from cost pressures and logistical issues.
Fevertree Drinks Earnings Call Transcript: H2 2021
Fevertree Drinks Earnings Call Transcript: H1 2021
Fevertree Drinks Earnings Call Transcript: H2 2020
Fevertree Drinks shares slump on margin guidance
Shares of Fevertree Drinks fell as much as 11% as the maker of tonic water reported a 29% drop in earnings per share in 2020 on a 3% decline in revenue. It expects revenue growth of between 12% to 16%...
3 Consumer Products 'Traveling' Strongly For Shareholders
As mentioned in our past article, "travel-ability" varies a lot across consumer products.
Goldman Sachs backs these European stocks as acquisition targets
Goldman Sachs has tipped several European technology, insurance and utility companies for acquisition in the latest reshuffle of its M&A basket for the region.
Fevertree Drinks co-founder to step down as non-executive deputy chairman
Britain's Fevertree Drinks said on Wednesday co-founder Charles Rolls plans to step down from his role as non-executive deputy chairman at the company's annual general meeting in June.